Published in Elder Law Weekly, March 3rd, 2010
"This stud), primarily sought to evaluate the survival benefit of first-line irinotecan use in a group of Medicare patients with stage W (metastatic) colorectal cancer. Data on chemotherapy users with a diagnosis of colorectal cancer reported between 1998 and 2002 were obtained from the Surveillance Epidemiology and End Results (SEER)-Medicare database....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.